StatLab Acquires Histoserve GmbH and Remaining Stake in Diapath France SAS
August 13, 2025
StatLab Medical Products completed the acquisitions of Germany-based Histoserve GmbH and the remaining stake in Diapath France SAS, bringing both businesses into the Diapath/StatLab European organization. The transactions expand StatLab’s direct commercial presence across the four largest European pathology markets (France, Germany, Italy and the UK) and strengthen service, distribution and equipment capabilities for pathology laboratories in those markets.
- Buyers
- StatLab Medical Products, Diapath S.p.A (a StatLab company)
- Targets
- Histoserve GmbH, Diapath France SAS
- Sellers
- Wolfgang Jakobi, Jacques Hannaby
- Industry
- Medical Devices
- Location
- Lower Saxony, Germany
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Leica Biosystems Acquires StatLab Medical Products
September 28, 2026
Medical Devices
Leica Biosystems, a Danaher company, completed its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity on September 28, 2026. StatLab’s pre-analytical pathology consumables and equipment add specimen collection and preparation capabilities to Leica Biosystems’ pathology portfolio, broadening its offering from specimen collection through digital imaging and AI-enabled diagnosis.
-
Leica Biosystems to Acquire StatLab Medical Products From Linden Capital Partners and Audax Private Equity
July 14, 2026
Medical Devices
Leica Biosystems, a Danaher company, signed a definitive agreement to acquire StatLab Medical Products. StatLab is currently owned by Linden Capital Partners and Audax Private Equity, and the transaction is subject to customary closing conditions. Financial terms were not disclosed and the deal was expected to close by the end of 2026.
-
StatLab Medical Products Acquires Poly Scientific R&D
March 26, 2024
Medical Devices
StatLab Medical Products has acquired Poly Scientific R&D, a Bay Shore, New York-based manufacturer of pathology stains, reagents and tissue controls. The deal adds tissue control slide manufacturing and other anatomic pathology consumables to StatLab’s portfolio, expanding its manufacturing capabilities and market presence.
-
StatLab Medical Products Acquires CellPath Ltd.
June 8, 2022
Medical Devices
StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, acquired UK-based CellPath Ltd., a manufacturer and supplier focused on the histology and cytology markets. The deal adds injection-molding manufacturing capabilities, proprietary products (including the CellNass archiving service), and an established European customer base to support StatLab's international growth.
-
Audax Private Equity and Linden Capital Partners Acquire StatLab Medical Products
January 12, 2021
Medical Devices
Audax Private Equity and Linden Capital Partners have acquired StatLab Medical Products, a McKinney, Texas-based manufacturer and distributor of histology, cytology and immunohistochemistry consumables, reagents, and equipment. The deal — a purchase from Cressey & Company LP — positions StatLab for accelerated organic growth and buy-and-build activity to expand its product suite and customer base.
-
StageBio Acquires TPL Path Labs
October 21, 2020
Healthcare Services
StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.